Global Neoantigen Vaccine Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Neoantigen Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neoantigen Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neoantigen Vaccine market in any manner.
Global Neoantigen Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Merck & Co Inc
Eli Lilly and Company
BioNTech
Roche Holding AG
OSE Immunotherapeutics
Gritstone Bio
Moderna
Avidea Technologies
Vaccibody AS
Agenus Inc
Novogene
ZIOPHARM Oncology
ISA Pharmaceuticals
BrightPath Biotherapeutics
Vaximm AG
Medigene AG
Genocea Biosciences Inc
Advaxis
Nouscom
Market Segmentation (by Type)
Personalized Vaccine
Off-the shelf Vaccine
Market Segmentation (by Application)
Lung Cancer
Melanoma Cancer
Gastrointestinal Cancer
Brain Cancer
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neoantigen Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Neoantigen Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neoantigen Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neoantigen Vaccine market in any manner.
Global Neoantigen Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Merck & Co Inc
Eli Lilly and Company
BioNTech
Roche Holding AG
OSE Immunotherapeutics
Gritstone Bio
Moderna
Avidea Technologies
Vaccibody AS
Agenus Inc
Novogene
ZIOPHARM Oncology
ISA Pharmaceuticals
BrightPath Biotherapeutics
Vaximm AG
Medigene AG
Genocea Biosciences Inc
Advaxis
Nouscom
Market Segmentation (by Type)
Personalized Vaccine
Off-the shelf Vaccine
Market Segmentation (by Application)
Lung Cancer
Melanoma Cancer
Gastrointestinal Cancer
Brain Cancer
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Neoantigen Vaccine Market
- Overview of the regional outlook of the Neoantigen Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neoantigen Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neoantigen Vaccine
1.2 Key Market Segments
1.2.1 Neoantigen Vaccine Segment by Type
1.2.2 Neoantigen Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEOANTIGEN VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neoantigen Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neoantigen Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEOANTIGEN VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Neoantigen Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Neoantigen Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Neoantigen Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neoantigen Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neoantigen Vaccine Sales Sites, Area Served, Product Type
3.6 Neoantigen Vaccine Market Competitive Situation and Trends
3.6.1 Neoantigen Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neoantigen Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEOANTIGEN VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Neoantigen Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEOANTIGEN VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEOANTIGEN VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neoantigen Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Neoantigen Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Neoantigen Vaccine Price by Type (2019-2024)
7 NEOANTIGEN VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neoantigen Vaccine Market Sales by Application (2019-2024)
7.3 Global Neoantigen Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Neoantigen Vaccine Sales Growth Rate by Application (2019-2024)
8 NEOANTIGEN VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Neoantigen Vaccine Sales by Region
8.1.1 Global Neoantigen Vaccine Sales by Region
8.1.2 Global Neoantigen Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Neoantigen Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neoantigen Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neoantigen Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neoantigen Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neoantigen Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Neoantigen Vaccine Basic Information
9.1.2 Pfizer Neoantigen Vaccine Product Overview
9.1.3 Pfizer Neoantigen Vaccine Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Neoantigen Vaccine SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Merck and Co Inc
9.2.1 Merck and Co Inc Neoantigen Vaccine Basic Information
9.2.2 Merck and Co Inc Neoantigen Vaccine Product Overview
9.2.3 Merck and Co Inc Neoantigen Vaccine Product Market Performance
9.2.4 Merck and Co Inc Business Overview
9.2.5 Merck and Co Inc Neoantigen Vaccine SWOT Analysis
9.2.6 Merck and Co Inc Recent Developments
9.3 Eli Lilly and Company
9.3.1 Eli Lilly and Company Neoantigen Vaccine Basic Information
9.3.2 Eli Lilly and Company Neoantigen Vaccine Product Overview
9.3.3 Eli Lilly and Company Neoantigen Vaccine Product Market Performance
9.3.4 Eli Lilly and Company Neoantigen Vaccine SWOT Analysis
9.3.5 Eli Lilly and Company Business Overview
9.3.6 Eli Lilly and Company Recent Developments
9.4 BioNTech
9.4.1 BioNTech Neoantigen Vaccine Basic Information
9.4.2 BioNTech Neoantigen Vaccine Product Overview
9.4.3 BioNTech Neoantigen Vaccine Product Market Performance
9.4.4 BioNTech Business Overview
9.4.5 BioNTech Recent Developments
9.5 Roche Holding AG
9.5.1 Roche Holding AG Neoantigen Vaccine Basic Information
9.5.2 Roche Holding AG Neoantigen Vaccine Product Overview
9.5.3 Roche Holding AG Neoantigen Vaccine Product Market Performance
9.5.4 Roche Holding AG Business Overview
9.5.5 Roche Holding AG Recent Developments
9.6 OSE Immunotherapeutics
9.6.1 OSE Immunotherapeutics Neoantigen Vaccine Basic Information
9.6.2 OSE Immunotherapeutics Neoantigen Vaccine Product Overview
9.6.3 OSE Immunotherapeutics Neoantigen Vaccine Product Market Performance
9.6.4 OSE Immunotherapeutics Business Overview
9.6.5 OSE Immunotherapeutics Recent Developments
9.7 Gritstone Bio
9.7.1 Gritstone Bio Neoantigen Vaccine Basic Information
9.7.2 Gritstone Bio Neoantigen Vaccine Product Overview
9.7.3 Gritstone Bio Neoantigen Vaccine Product Market Performance
9.7.4 Gritstone Bio Business Overview
9.7.5 Gritstone Bio Recent Developments
9.8 Moderna
9.8.1 Moderna Neoantigen Vaccine Basic Information
9.8.2 Moderna Neoantigen Vaccine Product Overview
9.8.3 Moderna Neoantigen Vaccine Product Market Performance
9.8.4 Moderna Business Overview
9.8.5 Moderna Recent Developments
9.9 Avidea Technologies
9.9.1 Avidea Technologies Neoantigen Vaccine Basic Information
9.9.2 Avidea Technologies Neoantigen Vaccine Product Overview
9.9.3 Avidea Technologies Neoantigen Vaccine Product Market Performance
9.9.4 Avidea Technologies Business Overview
9.9.5 Avidea Technologies Recent Developments
9.10 Vaccibody AS
9.10.1 Vaccibody AS Neoantigen Vaccine Basic Information
9.10.2 Vaccibody AS Neoantigen Vaccine Product Overview
9.10.3 Vaccibody AS Neoantigen Vaccine Product Market Performance
9.10.4 Vaccibody AS Business Overview
9.10.5 Vaccibody AS Recent Developments
9.11 Agenus Inc
9.11.1 Agenus Inc Neoantigen Vaccine Basic Information
9.11.2 Agenus Inc Neoantigen Vaccine Product Overview
9.11.3 Agenus Inc Neoantigen Vaccine Product Market Performance
9.11.4 Agenus Inc Business Overview
9.11.5 Agenus Inc Recent Developments
9.12 Novogene
9.12.1 Novogene Neoantigen Vaccine Basic Information
9.12.2 Novogene Neoantigen Vaccine Product Overview
9.12.3 Novogene Neoantigen Vaccine Product Market Performance
9.12.4 Novogene Business Overview
9.12.5 Novogene Recent Developments
9.13 ZIOPHARM Oncology
9.13.1 ZIOPHARM Oncology Neoantigen Vaccine Basic Information
9.13.2 ZIOPHARM Oncology Neoantigen Vaccine Product Overview
9.13.3 ZIOPHARM Oncology Neoantigen Vaccine Product Market Performance
9.13.4 ZIOPHARM Oncology Business Overview
9.13.5 ZIOPHARM Oncology Recent Developments
9.14 ISA Pharmaceuticals
9.14.1 ISA Pharmaceuticals Neoantigen Vaccine Basic Information
9.14.2 ISA Pharmaceuticals Neoantigen Vaccine Product Overview
9.14.3 ISA Pharmaceuticals Neoantigen Vaccine Product Market Performance
9.14.4 ISA Pharmaceuticals Business Overview
9.14.5 ISA Pharmaceuticals Recent Developments
9.15 BrightPath Biotherapeutics
9.15.1 BrightPath Biotherapeutics Neoantigen Vaccine Basic Information
9.15.2 BrightPath Biotherapeutics Neoantigen Vaccine Product Overview
9.15.3 BrightPath Biotherapeutics Neoantigen Vaccine Product Market Performance
9.15.4 BrightPath Biotherapeutics Business Overview
9.15.5 BrightPath Biotherapeutics Recent Developments
9.16 Vaximm AG
9.16.1 Vaximm AG Neoantigen Vaccine Basic Information
9.16.2 Vaximm AG Neoantigen Vaccine Product Overview
9.16.3 Vaximm AG Neoantigen Vaccine Product Market Performance
9.16.4 Vaximm AG Business Overview
9.16.5 Vaximm AG Recent Developments
9.17 Medigene AG
9.17.1 Medigene AG Neoantigen Vaccine Basic Information
9.17.2 Medigene AG Neoantigen Vaccine Product Overview
9.17.3 Medigene AG Neoantigen Vaccine Product Market Performance
9.17.4 Medigene AG Business Overview
9.17.5 Medigene AG Recent Developments
9.18 Genocea Biosciences Inc
9.18.1 Genocea Biosciences Inc Neoantigen Vaccine Basic Information
9.18.2 Genocea Biosciences Inc Neoantigen Vaccine Product Overview
9.18.3 Genocea Biosciences Inc Neoantigen Vaccine Product Market Performance
9.18.4 Genocea Biosciences Inc Business Overview
9.18.5 Genocea Biosciences Inc Recent Developments
9.19 Advaxis
9.19.1 Advaxis Neoantigen Vaccine Basic Information
9.19.2 Advaxis Neoantigen Vaccine Product Overview
9.19.3 Advaxis Neoantigen Vaccine Product Market Performance
9.19.4 Advaxis Business Overview
9.19.5 Advaxis Recent Developments
9.20 Nouscom
9.20.1 Nouscom Neoantigen Vaccine Basic Information
9.20.2 Nouscom Neoantigen Vaccine Product Overview
9.20.3 Nouscom Neoantigen Vaccine Product Market Performance
9.20.4 Nouscom Business Overview
9.20.5 Nouscom Recent Developments
10 NEOANTIGEN VACCINE MARKET FORECAST BY REGION
10.1 Global Neoantigen Vaccine Market Size Forecast
10.2 Global Neoantigen Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neoantigen Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Neoantigen Vaccine Market Size Forecast by Region
10.2.4 South America Neoantigen Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neoantigen Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Neoantigen Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neoantigen Vaccine by Type (2025-2030)
11.1.2 Global Neoantigen Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neoantigen Vaccine by Type (2025-2030)
11.2 Global Neoantigen Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Neoantigen Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Neoantigen Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Neoantigen Vaccine
1.2 Key Market Segments
1.2.1 Neoantigen Vaccine Segment by Type
1.2.2 Neoantigen Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEOANTIGEN VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neoantigen Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neoantigen Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEOANTIGEN VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Neoantigen Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Neoantigen Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Neoantigen Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neoantigen Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neoantigen Vaccine Sales Sites, Area Served, Product Type
3.6 Neoantigen Vaccine Market Competitive Situation and Trends
3.6.1 Neoantigen Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neoantigen Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEOANTIGEN VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Neoantigen Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEOANTIGEN VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEOANTIGEN VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neoantigen Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Neoantigen Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Neoantigen Vaccine Price by Type (2019-2024)
7 NEOANTIGEN VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neoantigen Vaccine Market Sales by Application (2019-2024)
7.3 Global Neoantigen Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Neoantigen Vaccine Sales Growth Rate by Application (2019-2024)
8 NEOANTIGEN VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Neoantigen Vaccine Sales by Region
8.1.1 Global Neoantigen Vaccine Sales by Region
8.1.2 Global Neoantigen Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Neoantigen Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neoantigen Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neoantigen Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neoantigen Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neoantigen Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Neoantigen Vaccine Basic Information
9.1.2 Pfizer Neoantigen Vaccine Product Overview
9.1.3 Pfizer Neoantigen Vaccine Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Neoantigen Vaccine SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Merck and Co Inc
9.2.1 Merck and Co Inc Neoantigen Vaccine Basic Information
9.2.2 Merck and Co Inc Neoantigen Vaccine Product Overview
9.2.3 Merck and Co Inc Neoantigen Vaccine Product Market Performance
9.2.4 Merck and Co Inc Business Overview
9.2.5 Merck and Co Inc Neoantigen Vaccine SWOT Analysis
9.2.6 Merck and Co Inc Recent Developments
9.3 Eli Lilly and Company
9.3.1 Eli Lilly and Company Neoantigen Vaccine Basic Information
9.3.2 Eli Lilly and Company Neoantigen Vaccine Product Overview
9.3.3 Eli Lilly and Company Neoantigen Vaccine Product Market Performance
9.3.4 Eli Lilly and Company Neoantigen Vaccine SWOT Analysis
9.3.5 Eli Lilly and Company Business Overview
9.3.6 Eli Lilly and Company Recent Developments
9.4 BioNTech
9.4.1 BioNTech Neoantigen Vaccine Basic Information
9.4.2 BioNTech Neoantigen Vaccine Product Overview
9.4.3 BioNTech Neoantigen Vaccine Product Market Performance
9.4.4 BioNTech Business Overview
9.4.5 BioNTech Recent Developments
9.5 Roche Holding AG
9.5.1 Roche Holding AG Neoantigen Vaccine Basic Information
9.5.2 Roche Holding AG Neoantigen Vaccine Product Overview
9.5.3 Roche Holding AG Neoantigen Vaccine Product Market Performance
9.5.4 Roche Holding AG Business Overview
9.5.5 Roche Holding AG Recent Developments
9.6 OSE Immunotherapeutics
9.6.1 OSE Immunotherapeutics Neoantigen Vaccine Basic Information
9.6.2 OSE Immunotherapeutics Neoantigen Vaccine Product Overview
9.6.3 OSE Immunotherapeutics Neoantigen Vaccine Product Market Performance
9.6.4 OSE Immunotherapeutics Business Overview
9.6.5 OSE Immunotherapeutics Recent Developments
9.7 Gritstone Bio
9.7.1 Gritstone Bio Neoantigen Vaccine Basic Information
9.7.2 Gritstone Bio Neoantigen Vaccine Product Overview
9.7.3 Gritstone Bio Neoantigen Vaccine Product Market Performance
9.7.4 Gritstone Bio Business Overview
9.7.5 Gritstone Bio Recent Developments
9.8 Moderna
9.8.1 Moderna Neoantigen Vaccine Basic Information
9.8.2 Moderna Neoantigen Vaccine Product Overview
9.8.3 Moderna Neoantigen Vaccine Product Market Performance
9.8.4 Moderna Business Overview
9.8.5 Moderna Recent Developments
9.9 Avidea Technologies
9.9.1 Avidea Technologies Neoantigen Vaccine Basic Information
9.9.2 Avidea Technologies Neoantigen Vaccine Product Overview
9.9.3 Avidea Technologies Neoantigen Vaccine Product Market Performance
9.9.4 Avidea Technologies Business Overview
9.9.5 Avidea Technologies Recent Developments
9.10 Vaccibody AS
9.10.1 Vaccibody AS Neoantigen Vaccine Basic Information
9.10.2 Vaccibody AS Neoantigen Vaccine Product Overview
9.10.3 Vaccibody AS Neoantigen Vaccine Product Market Performance
9.10.4 Vaccibody AS Business Overview
9.10.5 Vaccibody AS Recent Developments
9.11 Agenus Inc
9.11.1 Agenus Inc Neoantigen Vaccine Basic Information
9.11.2 Agenus Inc Neoantigen Vaccine Product Overview
9.11.3 Agenus Inc Neoantigen Vaccine Product Market Performance
9.11.4 Agenus Inc Business Overview
9.11.5 Agenus Inc Recent Developments
9.12 Novogene
9.12.1 Novogene Neoantigen Vaccine Basic Information
9.12.2 Novogene Neoantigen Vaccine Product Overview
9.12.3 Novogene Neoantigen Vaccine Product Market Performance
9.12.4 Novogene Business Overview
9.12.5 Novogene Recent Developments
9.13 ZIOPHARM Oncology
9.13.1 ZIOPHARM Oncology Neoantigen Vaccine Basic Information
9.13.2 ZIOPHARM Oncology Neoantigen Vaccine Product Overview
9.13.3 ZIOPHARM Oncology Neoantigen Vaccine Product Market Performance
9.13.4 ZIOPHARM Oncology Business Overview
9.13.5 ZIOPHARM Oncology Recent Developments
9.14 ISA Pharmaceuticals
9.14.1 ISA Pharmaceuticals Neoantigen Vaccine Basic Information
9.14.2 ISA Pharmaceuticals Neoantigen Vaccine Product Overview
9.14.3 ISA Pharmaceuticals Neoantigen Vaccine Product Market Performance
9.14.4 ISA Pharmaceuticals Business Overview
9.14.5 ISA Pharmaceuticals Recent Developments
9.15 BrightPath Biotherapeutics
9.15.1 BrightPath Biotherapeutics Neoantigen Vaccine Basic Information
9.15.2 BrightPath Biotherapeutics Neoantigen Vaccine Product Overview
9.15.3 BrightPath Biotherapeutics Neoantigen Vaccine Product Market Performance
9.15.4 BrightPath Biotherapeutics Business Overview
9.15.5 BrightPath Biotherapeutics Recent Developments
9.16 Vaximm AG
9.16.1 Vaximm AG Neoantigen Vaccine Basic Information
9.16.2 Vaximm AG Neoantigen Vaccine Product Overview
9.16.3 Vaximm AG Neoantigen Vaccine Product Market Performance
9.16.4 Vaximm AG Business Overview
9.16.5 Vaximm AG Recent Developments
9.17 Medigene AG
9.17.1 Medigene AG Neoantigen Vaccine Basic Information
9.17.2 Medigene AG Neoantigen Vaccine Product Overview
9.17.3 Medigene AG Neoantigen Vaccine Product Market Performance
9.17.4 Medigene AG Business Overview
9.17.5 Medigene AG Recent Developments
9.18 Genocea Biosciences Inc
9.18.1 Genocea Biosciences Inc Neoantigen Vaccine Basic Information
9.18.2 Genocea Biosciences Inc Neoantigen Vaccine Product Overview
9.18.3 Genocea Biosciences Inc Neoantigen Vaccine Product Market Performance
9.18.4 Genocea Biosciences Inc Business Overview
9.18.5 Genocea Biosciences Inc Recent Developments
9.19 Advaxis
9.19.1 Advaxis Neoantigen Vaccine Basic Information
9.19.2 Advaxis Neoantigen Vaccine Product Overview
9.19.3 Advaxis Neoantigen Vaccine Product Market Performance
9.19.4 Advaxis Business Overview
9.19.5 Advaxis Recent Developments
9.20 Nouscom
9.20.1 Nouscom Neoantigen Vaccine Basic Information
9.20.2 Nouscom Neoantigen Vaccine Product Overview
9.20.3 Nouscom Neoantigen Vaccine Product Market Performance
9.20.4 Nouscom Business Overview
9.20.5 Nouscom Recent Developments
10 NEOANTIGEN VACCINE MARKET FORECAST BY REGION
10.1 Global Neoantigen Vaccine Market Size Forecast
10.2 Global Neoantigen Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neoantigen Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Neoantigen Vaccine Market Size Forecast by Region
10.2.4 South America Neoantigen Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neoantigen Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Neoantigen Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neoantigen Vaccine by Type (2025-2030)
11.1.2 Global Neoantigen Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neoantigen Vaccine by Type (2025-2030)
11.2 Global Neoantigen Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Neoantigen Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Neoantigen Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neoantigen Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Neoantigen Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Neoantigen Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Neoantigen Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Neoantigen Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Vaccine as of 2022)
Table 10. Global Market Neoantigen Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Neoantigen Vaccine Sales Sites and Area Served
Table 12. Manufacturers Neoantigen Vaccine Product Type
Table 13. Global Neoantigen Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neoantigen Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neoantigen Vaccine Market Challenges
Table 22. Global Neoantigen Vaccine Sales by Type (Kilotons)
Table 23. Global Neoantigen Vaccine Market Size by Type (M USD)
Table 24. Global Neoantigen Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Neoantigen Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Neoantigen Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Neoantigen Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Neoantigen Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Neoantigen Vaccine Sales (Kilotons) by Application
Table 30. Global Neoantigen Vaccine Market Size by Application
Table 31. Global Neoantigen Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Neoantigen Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Neoantigen Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Neoantigen Vaccine Market Share by Application (2019-2024)
Table 35. Global Neoantigen Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Neoantigen Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Neoantigen Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Neoantigen Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Neoantigen Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Neoantigen Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Neoantigen Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Neoantigen Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Neoantigen Vaccine Basic Information
Table 44. Pfizer Neoantigen Vaccine Product Overview
Table 45. Pfizer Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Neoantigen Vaccine SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Merck and Co Inc Neoantigen Vaccine Basic Information
Table 50. Merck and Co Inc Neoantigen Vaccine Product Overview
Table 51. Merck and Co Inc Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck and Co Inc Business Overview
Table 53. Merck and Co Inc Neoantigen Vaccine SWOT Analysis
Table 54. Merck and Co Inc Recent Developments
Table 55. Eli Lilly and Company Neoantigen Vaccine Basic Information
Table 56. Eli Lilly and Company Neoantigen Vaccine Product Overview
Table 57. Eli Lilly and Company Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Eli Lilly and Company Neoantigen Vaccine SWOT Analysis
Table 59. Eli Lilly and Company Business Overview
Table 60. Eli Lilly and Company Recent Developments
Table 61. BioNTech Neoantigen Vaccine Basic Information
Table 62. BioNTech Neoantigen Vaccine Product Overview
Table 63. BioNTech Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. BioNTech Business Overview
Table 65. BioNTech Recent Developments
Table 66. Roche Holding AG Neoantigen Vaccine Basic Information
Table 67. Roche Holding AG Neoantigen Vaccine Product Overview
Table 68. Roche Holding AG Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Roche Holding AG Business Overview
Table 70. Roche Holding AG Recent Developments
Table 71. OSE Immunotherapeutics Neoantigen Vaccine Basic Information
Table 72. OSE Immunotherapeutics Neoantigen Vaccine Product Overview
Table 73. OSE Immunotherapeutics Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. OSE Immunotherapeutics Business Overview
Table 75. OSE Immunotherapeutics Recent Developments
Table 76. Gritstone Bio Neoantigen Vaccine Basic Information
Table 77. Gritstone Bio Neoantigen Vaccine Product Overview
Table 78. Gritstone Bio Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Gritstone Bio Business Overview
Table 80. Gritstone Bio Recent Developments
Table 81. Moderna Neoantigen Vaccine Basic Information
Table 82. Moderna Neoantigen Vaccine Product Overview
Table 83. Moderna Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Moderna Business Overview
Table 85. Moderna Recent Developments
Table 86. Avidea Technologies Neoantigen Vaccine Basic Information
Table 87. Avidea Technologies Neoantigen Vaccine Product Overview
Table 88. Avidea Technologies Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Avidea Technologies Business Overview
Table 90. Avidea Technologies Recent Developments
Table 91. Vaccibody AS Neoantigen Vaccine Basic Information
Table 92. Vaccibody AS Neoantigen Vaccine Product Overview
Table 93. Vaccibody AS Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Vaccibody AS Business Overview
Table 95. Vaccibody AS Recent Developments
Table 96. Agenus Inc Neoantigen Vaccine Basic Information
Table 97. Agenus Inc Neoantigen Vaccine Product Overview
Table 98. Agenus Inc Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Agenus Inc Business Overview
Table 100. Agenus Inc Recent Developments
Table 101. Novogene Neoantigen Vaccine Basic Information
Table 102. Novogene Neoantigen Vaccine Product Overview
Table 103. Novogene Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Novogene Business Overview
Table 105. Novogene Recent Developments
Table 106. ZIOPHARM Oncology Neoantigen Vaccine Basic Information
Table 107. ZIOPHARM Oncology Neoantigen Vaccine Product Overview
Table 108. ZIOPHARM Oncology Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. ZIOPHARM Oncology Business Overview
Table 110. ZIOPHARM Oncology Recent Developments
Table 111. ISA Pharmaceuticals Neoantigen Vaccine Basic Information
Table 112. ISA Pharmaceuticals Neoantigen Vaccine Product Overview
Table 113. ISA Pharmaceuticals Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. ISA Pharmaceuticals Business Overview
Table 115. ISA Pharmaceuticals Recent Developments
Table 116. BrightPath Biotherapeutics Neoantigen Vaccine Basic Information
Table 117. BrightPath Biotherapeutics Neoantigen Vaccine Product Overview
Table 118. BrightPath Biotherapeutics Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. BrightPath Biotherapeutics Business Overview
Table 120. BrightPath Biotherapeutics Recent Developments
Table 121. Vaximm AG Neoantigen Vaccine Basic Information
Table 122. Vaximm AG Neoantigen Vaccine Product Overview
Table 123. Vaximm AG Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Vaximm AG Business Overview
Table 125. Vaximm AG Recent Developments
Table 126. Medigene AG Neoantigen Vaccine Basic Information
Table 127. Medigene AG Neoantigen Vaccine Product Overview
Table 128. Medigene AG Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Medigene AG Business Overview
Table 130. Medigene AG Recent Developments
Table 131. Genocea Biosciences Inc Neoantigen Vaccine Basic Information
Table 132. Genocea Biosciences Inc Neoantigen Vaccine Product Overview
Table 133. Genocea Biosciences Inc Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Genocea Biosciences Inc Business Overview
Table 135. Genocea Biosciences Inc Recent Developments
Table 136. Advaxis Neoantigen Vaccine Basic Information
Table 137. Advaxis Neoantigen Vaccine Product Overview
Table 138. Advaxis Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Advaxis Business Overview
Table 140. Advaxis Recent Developments
Table 141. Nouscom Neoantigen Vaccine Basic Information
Table 142. Nouscom Neoantigen Vaccine Product Overview
Table 143. Nouscom Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Nouscom Business Overview
Table 145. Nouscom Recent Developments
Table 146. Global Neoantigen Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 147. Global Neoantigen Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Neoantigen Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 149. North America Neoantigen Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Neoantigen Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 151. Europe Neoantigen Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Neoantigen Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 153. Asia Pacific Neoantigen Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Neoantigen Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 155. South America Neoantigen Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Neoantigen Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Neoantigen Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Neoantigen Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 159. Global Neoantigen Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Neoantigen Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 161. Global Neoantigen Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 162. Global Neoantigen Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neoantigen Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Neoantigen Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Neoantigen Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Neoantigen Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Neoantigen Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Vaccine as of 2022)
Table 10. Global Market Neoantigen Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Neoantigen Vaccine Sales Sites and Area Served
Table 12. Manufacturers Neoantigen Vaccine Product Type
Table 13. Global Neoantigen Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neoantigen Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neoantigen Vaccine Market Challenges
Table 22. Global Neoantigen Vaccine Sales by Type (Kilotons)
Table 23. Global Neoantigen Vaccine Market Size by Type (M USD)
Table 24. Global Neoantigen Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Neoantigen Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Neoantigen Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Neoantigen Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Neoantigen Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Neoantigen Vaccine Sales (Kilotons) by Application
Table 30. Global Neoantigen Vaccine Market Size by Application
Table 31. Global Neoantigen Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Neoantigen Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Neoantigen Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Neoantigen Vaccine Market Share by Application (2019-2024)
Table 35. Global Neoantigen Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Neoantigen Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Neoantigen Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Neoantigen Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Neoantigen Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Neoantigen Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Neoantigen Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Neoantigen Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Neoantigen Vaccine Basic Information
Table 44. Pfizer Neoantigen Vaccine Product Overview
Table 45. Pfizer Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Neoantigen Vaccine SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Merck and Co Inc Neoantigen Vaccine Basic Information
Table 50. Merck and Co Inc Neoantigen Vaccine Product Overview
Table 51. Merck and Co Inc Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck and Co Inc Business Overview
Table 53. Merck and Co Inc Neoantigen Vaccine SWOT Analysis
Table 54. Merck and Co Inc Recent Developments
Table 55. Eli Lilly and Company Neoantigen Vaccine Basic Information
Table 56. Eli Lilly and Company Neoantigen Vaccine Product Overview
Table 57. Eli Lilly and Company Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Eli Lilly and Company Neoantigen Vaccine SWOT Analysis
Table 59. Eli Lilly and Company Business Overview
Table 60. Eli Lilly and Company Recent Developments
Table 61. BioNTech Neoantigen Vaccine Basic Information
Table 62. BioNTech Neoantigen Vaccine Product Overview
Table 63. BioNTech Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. BioNTech Business Overview
Table 65. BioNTech Recent Developments
Table 66. Roche Holding AG Neoantigen Vaccine Basic Information
Table 67. Roche Holding AG Neoantigen Vaccine Product Overview
Table 68. Roche Holding AG Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Roche Holding AG Business Overview
Table 70. Roche Holding AG Recent Developments
Table 71. OSE Immunotherapeutics Neoantigen Vaccine Basic Information
Table 72. OSE Immunotherapeutics Neoantigen Vaccine Product Overview
Table 73. OSE Immunotherapeutics Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. OSE Immunotherapeutics Business Overview
Table 75. OSE Immunotherapeutics Recent Developments
Table 76. Gritstone Bio Neoantigen Vaccine Basic Information
Table 77. Gritstone Bio Neoantigen Vaccine Product Overview
Table 78. Gritstone Bio Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Gritstone Bio Business Overview
Table 80. Gritstone Bio Recent Developments
Table 81. Moderna Neoantigen Vaccine Basic Information
Table 82. Moderna Neoantigen Vaccine Product Overview
Table 83. Moderna Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Moderna Business Overview
Table 85. Moderna Recent Developments
Table 86. Avidea Technologies Neoantigen Vaccine Basic Information
Table 87. Avidea Technologies Neoantigen Vaccine Product Overview
Table 88. Avidea Technologies Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Avidea Technologies Business Overview
Table 90. Avidea Technologies Recent Developments
Table 91. Vaccibody AS Neoantigen Vaccine Basic Information
Table 92. Vaccibody AS Neoantigen Vaccine Product Overview
Table 93. Vaccibody AS Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Vaccibody AS Business Overview
Table 95. Vaccibody AS Recent Developments
Table 96. Agenus Inc Neoantigen Vaccine Basic Information
Table 97. Agenus Inc Neoantigen Vaccine Product Overview
Table 98. Agenus Inc Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Agenus Inc Business Overview
Table 100. Agenus Inc Recent Developments
Table 101. Novogene Neoantigen Vaccine Basic Information
Table 102. Novogene Neoantigen Vaccine Product Overview
Table 103. Novogene Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Novogene Business Overview
Table 105. Novogene Recent Developments
Table 106. ZIOPHARM Oncology Neoantigen Vaccine Basic Information
Table 107. ZIOPHARM Oncology Neoantigen Vaccine Product Overview
Table 108. ZIOPHARM Oncology Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. ZIOPHARM Oncology Business Overview
Table 110. ZIOPHARM Oncology Recent Developments
Table 111. ISA Pharmaceuticals Neoantigen Vaccine Basic Information
Table 112. ISA Pharmaceuticals Neoantigen Vaccine Product Overview
Table 113. ISA Pharmaceuticals Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. ISA Pharmaceuticals Business Overview
Table 115. ISA Pharmaceuticals Recent Developments
Table 116. BrightPath Biotherapeutics Neoantigen Vaccine Basic Information
Table 117. BrightPath Biotherapeutics Neoantigen Vaccine Product Overview
Table 118. BrightPath Biotherapeutics Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. BrightPath Biotherapeutics Business Overview
Table 120. BrightPath Biotherapeutics Recent Developments
Table 121. Vaximm AG Neoantigen Vaccine Basic Information
Table 122. Vaximm AG Neoantigen Vaccine Product Overview
Table 123. Vaximm AG Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Vaximm AG Business Overview
Table 125. Vaximm AG Recent Developments
Table 126. Medigene AG Neoantigen Vaccine Basic Information
Table 127. Medigene AG Neoantigen Vaccine Product Overview
Table 128. Medigene AG Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Medigene AG Business Overview
Table 130. Medigene AG Recent Developments
Table 131. Genocea Biosciences Inc Neoantigen Vaccine Basic Information
Table 132. Genocea Biosciences Inc Neoantigen Vaccine Product Overview
Table 133. Genocea Biosciences Inc Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Genocea Biosciences Inc Business Overview
Table 135. Genocea Biosciences Inc Recent Developments
Table 136. Advaxis Neoantigen Vaccine Basic Information
Table 137. Advaxis Neoantigen Vaccine Product Overview
Table 138. Advaxis Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Advaxis Business Overview
Table 140. Advaxis Recent Developments
Table 141. Nouscom Neoantigen Vaccine Basic Information
Table 142. Nouscom Neoantigen Vaccine Product Overview
Table 143. Nouscom Neoantigen Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Nouscom Business Overview
Table 145. Nouscom Recent Developments
Table 146. Global Neoantigen Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 147. Global Neoantigen Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Neoantigen Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 149. North America Neoantigen Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Neoantigen Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 151. Europe Neoantigen Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Neoantigen Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 153. Asia Pacific Neoantigen Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Neoantigen Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 155. South America Neoantigen Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Neoantigen Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Neoantigen Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Neoantigen Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 159. Global Neoantigen Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Neoantigen Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 161. Global Neoantigen Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 162. Global Neoantigen Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Neoantigen Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neoantigen Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Neoantigen Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Neoantigen Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neoantigen Vaccine Market Size by Country (M USD)
Figure 11. Neoantigen Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Neoantigen Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Neoantigen Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neoantigen Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neoantigen Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neoantigen Vaccine Market Share by Type
Figure 18. Sales Market Share of Neoantigen Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Neoantigen Vaccine by Type in 2023
Figure 20. Market Size Share of Neoantigen Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Neoantigen Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neoantigen Vaccine Market Share by Application
Figure 24. Global Neoantigen Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Neoantigen Vaccine Sales Market Share by Application in 2023
Figure 26. Global Neoantigen Vaccine Market Share by Application (2019-2024)
Figure 27. Global Neoantigen Vaccine Market Share by Application in 2023
Figure 28. Global Neoantigen Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Neoantigen Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Neoantigen Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Neoantigen Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Neoantigen Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Neoantigen Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Neoantigen Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Neoantigen Vaccine Sales Market Share by Region in 2023
Figure 44. China Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Neoantigen Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Neoantigen Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Neoantigen Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Neoantigen Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Neoantigen Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Neoantigen Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Neoantigen Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Neoantigen Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Neoantigen Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Neoantigen Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Neoantigen Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neoantigen Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Neoantigen Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Neoantigen Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neoantigen Vaccine Market Size by Country (M USD)
Figure 11. Neoantigen Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Neoantigen Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Neoantigen Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neoantigen Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neoantigen Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neoantigen Vaccine Market Share by Type
Figure 18. Sales Market Share of Neoantigen Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Neoantigen Vaccine by Type in 2023
Figure 20. Market Size Share of Neoantigen Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Neoantigen Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neoantigen Vaccine Market Share by Application
Figure 24. Global Neoantigen Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Neoantigen Vaccine Sales Market Share by Application in 2023
Figure 26. Global Neoantigen Vaccine Market Share by Application (2019-2024)
Figure 27. Global Neoantigen Vaccine Market Share by Application in 2023
Figure 28. Global Neoantigen Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Neoantigen Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Neoantigen Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Neoantigen Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Neoantigen Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Neoantigen Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Neoantigen Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Neoantigen Vaccine Sales Market Share by Region in 2023
Figure 44. China Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Neoantigen Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Neoantigen Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Neoantigen Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Neoantigen Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Neoantigen Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Neoantigen Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Neoantigen Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Neoantigen Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Neoantigen Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Neoantigen Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Neoantigen Vaccine Market Share Forecast by Application (2025-2030)
